Press release
Transcat Announces Executive Equity Retention Awards Ahead of CEO Succession in FY2026
Strategic Move to Ensure Leadership Stability During Transition to New Chief Executive Officer ROCHESTER, N.Y.--(BUSINESS WIRE)-- Transcat, Inc. (Nasdaq:
About this update from Transcat, Inc.
[{"type":"text","content":"\nStrategic Move to Ensure Leadership Stability During Transition to New Chief Executive Officer\n\n\n ROCHESTER, N.Y.--(BUSINESS WIRE)--\nTranscat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leader in test measurement, control and calibration, today announced the approval of one-time equity retention awards for certain executive officers. This decision, made by the Compensation Committee of the Board of Directors, is part of the company's strategy to maintain leadership stability in tandem with the previously announced retirement of Chief Executive Officer Lee D. Rudow.\n\n\nThe retention awards, made in conjunction with Mr. Rudow’s plans to retire as CEO, aim to incentivize its executive team to remain focused on business operations and the successful completion of the CEO succession. Mr. Rudow will continue to serve in his current role until March 2026. Following the appointment of a new CEO, Mr. Rudow will transition to an advisory role through March 2027 to provide guidance and continuity for the company.\n\n\n“This strategic move underscores Transcat’s commitment to ensuring leadership continuity and stability during a critical transition period, ultimately benefiting our shareholders and positioning the company for future success,” commented Chairman of the Board Gary Haseley. “Our Search Committee is now evaluating internal and external candidates for our next CEO, and we expect to provide an update on our third quarter fiscal year 2026 conference call in early February. I have the utmost confidence in our current management team and believe they will continue to strengthen the company for the future and improve our long-term competitive position. Our incredible team, diversified portfolio of products and services, and new CEO will position Transcat to execute against our strategic priorities in fiscal 2026 and beyond.”\n\n\nAbout Transcat\n\n\nTranscat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace ...